• To my knowledge, there are no studies assessing early neonatal Magnesium sulphate administration with the purpose of neuroprotection. However, there are small studies regarding its use for persistent pulmonary hypertension of the newborn (e.g. DOI: 10.1093/tropej/50.4.219), and a Cochrane Systematic Review (doi: 10.1002/14651858.CD005588.pub2) that could not find eligible trials according to its standards.

I did a quick search on Pubmed and found several articles on this subject.

I selected some articles that might interest you:

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004661.pub3/full

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001060.pub2/full

https://onlinelibrary.wiley.com/doi/10.1111/dmcn.14038

https://www.karger.com/Article/FullText/484891

https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002988

Thanks, Icaro Raony.

Some of them would be helpful.

There are hardly any articles which have studied early neonatal outcome.

Would like to know whether Magnesium Sulphate is being used universally throughout the world in threatened preterm labour?

You could find something interesting from this article Article Antenatal magnesium sulphate and adverse neonatal outcomes: ...

Thanks. Will go through the article.

Interesting topic

Administration of magnesium without any definitive indication like hypomagnesemia or convulsion will be an ethical issue.